Literature DB >> 25278120

Multidisciplinary management of multiple sclerosis symptoms.

Philippe Gallien1, Jordi Gich, Bernardo F Sánchez-Dalmau, Wolfgang Feneberg.   

Abstract

BACKGROUND: Effective management of multisymptomatic chronic diseases such as multiple sclerosis (MS) requires a multimodal, interdisciplinary approach. At MS clinics, numerous healthcare specialties are coordinated to provide patients with quality clinical care for all aspects of their disease. Settings and resource availability may vary between countries. Four specific specialty services from different EU countries are examined in more detail.
SUMMARY: The multidisciplinary neurorehabilitation team in Rennes, France, provides specialized consultations (e.g. spasticity, urodynamic unit, devices), inpatient and outpatient intensive rehabilitation programs and therapeutic education. Management approaches are based on a patient's level of impairment as assessed by the Expanded Disability Status Scale. In Girona, Spain, neuropsychologists perform assessments as part of the neurological protocol for all patients with MS. Depending on the level of impairment and patients' characteristics (e.g. working or not working), cognitive deficits may be treated at home or at a neurorehabilitation center. In Barcelona, Spain, neuro-ophthalmologists are involved in the differential diagnosis and follow-up care of MS patients with visual disturbances; particular attention is given to patients' vision-related quality of life. Pain specialists at the Marianne Strauß Klinik in Berg, Germany, have developed a system for classifying MS pain syndromes and differentiating MS-related pain from non MS-related pain. Chronic pain management involves numerous disciplines and requires active engagement by patients in developing treatment plans. Key Messages: MS affects several body systems and patients invariably require specialized interdisciplinary support. Insight into services provided by various specialties and their fit within multidisciplinary care models at MS centers may facilitate the design or refinement of care models in other locations.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2014        PMID: 25278120     DOI: 10.1159/000367620

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  10 in total

1.  Outcomes and future directions for neuroimmunology/multiple sclerosis fellowship training: Survey of recent trainees.

Authors:  Le H Hua; Ahmed Z Obeidat; Erin E Longbrake
Journal:  Mult Scler Relat Disord       Date:  2020-06-10       Impact factor: 4.339

Review 2.  Psychological Treatments and Psychotherapies in the Neurorehabilitation of Pain: Evidences and Recommendations from the Italian Consensus Conference on Pain in Neurorehabilitation.

Authors:  Gianluca Castelnuovo; Emanuele M Giusti; Gian Mauro Manzoni; Donatella Saviola; Arianna Gatti; Samantha Gabrielli; Marco Lacerenza; Giada Pietrabissa; Roberto Cattivelli; Chiara A M Spatola; Stefania Corti; Margherita Novelli; Valentina Villa; Andrea Cottini; Carlo Lai; Francesco Pagnini; Lorys Castelli; Mario Tavola; Riccardo Torta; Marco Arreghini; Loredana Zanini; Amelia Brunani; Paolo Capodaglio; Guido E D'Aniello; Federica Scarpina; Andrea Brioschi; Lorenzo Priano; Alessandro Mauro; Giuseppe Riva; Claudia Repetto; Camillo Regalia; Enrico Molinari; Paolo Notaro; Stefano Paolucci; Giorgio Sandrini; Susan G Simpson; Brenda Wiederhold; Stefano Tamburin
Journal:  Front Psychol       Date:  2016-02-19

3.  Multidisciplinary Management of Sexual Dysfunction, Perineal Pain, and Elimination Dysfunction in a Woman with Multiple Sclerosis.

Authors:  Michela Miletta; Fabrizio Bogliatto; Leonardo Bacchio
Journal:  Int J MS Care       Date:  2017 Jan-Feb

4.  Nursing Interventions Focusing on Self-efficacy for Patients With Multiple Sclerosis in Rehabilitation: A Systematic Review.

Authors:  Rouven Brenner; Verena Witzig-Brändli; Janine Vetsch; Myrta Kohler
Journal:  Int J MS Care       Date:  2022-07-18

5.  Inosine, an Endogenous Purine Nucleoside, Suppresses Immune Responses and Protects Mice from Experimental Autoimmune Encephalomyelitis: a Role for A2A Adenosine Receptor.

Authors:  Stella Célio Junqueira; Igor Dos Santos Coelho; Vicente Lieberknecht; Mauricio Peña Cunha; João B Calixto; Ana Lúcia S Rodrigues; Adair Roberto Soares Santos; Rafael Cypriano Dutra
Journal:  Mol Neurobiol       Date:  2016-04-30       Impact factor: 5.590

Review 6.  An update on the causes, assessment and management of third division sensory trigeminal neuropathies.

Authors:  E Carter; Z Yilmaz; M Devine; T Renton
Journal:  Br Dent J       Date:  2016-06-24       Impact factor: 1.626

7.  Education Research: Multiple sclerosis and neuroimmunology fellowship training status in the United States.

Authors:  Ahmed Z Obeidat; Yasir N Jassam; Le H Hua; Gary Cutter; Corey C Ford; June Halper; Robert P Lisak; Nancy L Sicotte; Erin E Longbrake
Journal:  Neurology       Date:  2020-02-27       Impact factor: 11.800

8.  Tablet-based screening improves continence management in multiple sclerosis.

Authors:  Heidi N Beadnall; Kushi E Kuppanda; Annmaree O'Connell; Todd A Hardy; Stephen W Reddel; Michael H Barnett
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

Review 9.  Approved and Emerging Disease Modifying Therapies on Neurodegeneration in Multiple Sclerosis.

Authors:  Madeline Bross; Melody Hackett; Evanthia Bernitsas
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

10.  Managing communication changes in persons with multiple sclerosis: Findings from qualitative focus groups.

Authors:  Sarah El-Wahsh; Susan Balandin; Hans Bogaardt; Fiona Kumfor; Kirrie J Ballard
Journal:  Int J Lang Commun Disord       Date:  2022-03-26       Impact factor: 2.909

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.